U.S. Oligonucleotide Synthesis Market Is Slated To Witness Tremendous Growth In Future
U.S. Oligonucleotide Synthesis Market Summary The U.S. oligonucleotide synthesis market size was valued at USD 1.36 billion in 2023 and is anticipated to grow at a robust compound annual growth rate (CAGR) of 12.80% from 2024 to 2030. Growth is largely fueled by the increasing demand for synthetic DNA and RNA sequences across a wide range of applications, including molecular biology research, advanced diagnostics, and the development of innovative therapeutics. The market landscape is highly competitive, with a combination of well-established global leaders and emerging regional players striving to gain market share. Among the most prominent companies are Integrated DNA Technologies, Thermo Fisher Scientific, Eurofins Scientific, and Bio-Synthesis, Inc., which continue to hold a strong presence in the U.S. market through their innovative product portfolios and strategic initiatives. These leading companies are recognized for providing comprehensive and high-quality ol...